Examples therefor are the upregulation of the WNT receptor FZD7 found in certain breast cancers and hepatocellular carcinoma [20,21] or the downregulation of the WNT inhibitory factor 1 (WIF1) found in prostate, lung, breast and bladder cancers [22]. This evidence concerns the gene WIF1 and breast carcinoma.